1. Home
  2. COCP vs ABVE Comparison

COCP vs ABVE Comparison

Compare COCP & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • ABVE
  • Stock Information
  • Founded
  • COCP N/A
  • ABVE 2019
  • Country
  • COCP United States
  • ABVE Canada
  • Employees
  • COCP N/A
  • ABVE N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • COCP Health Care
  • ABVE Consumer Staples
  • Exchange
  • COCP Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • COCP 18.2M
  • ABVE 21.3M
  • IPO Year
  • COCP N/A
  • ABVE N/A
  • Fundamental
  • Price
  • COCP $2.04
  • ABVE $0.53
  • Analyst Decision
  • COCP Strong Buy
  • ABVE
  • Analyst Count
  • COCP 1
  • ABVE 0
  • Target Price
  • COCP $7.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • COCP 18.6K
  • ABVE 34.2K
  • Earning Date
  • COCP 11-11-2024
  • ABVE 11-15-2024
  • Dividend Yield
  • COCP N/A
  • ABVE N/A
  • EPS Growth
  • COCP N/A
  • ABVE N/A
  • EPS
  • COCP N/A
  • ABVE N/A
  • Revenue
  • COCP N/A
  • ABVE $275,376,450.00
  • Revenue This Year
  • COCP N/A
  • ABVE N/A
  • Revenue Next Year
  • COCP N/A
  • ABVE N/A
  • P/E Ratio
  • COCP N/A
  • ABVE N/A
  • Revenue Growth
  • COCP N/A
  • ABVE N/A
  • 52 Week Low
  • COCP $1.33
  • ABVE $0.49
  • 52 Week High
  • COCP $3.10
  • ABVE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • COCP 61.73
  • ABVE N/A
  • Support Level
  • COCP $1.66
  • ABVE N/A
  • Resistance Level
  • COCP $1.87
  • ABVE N/A
  • Average True Range (ATR)
  • COCP 0.15
  • ABVE 0.00
  • MACD
  • COCP 0.04
  • ABVE 0.00
  • Stochastic Oscillator
  • COCP 48.10
  • ABVE 0.00

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: